paroxetine has been researched along with Heart Failure in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Chuprun, JK; Feldman, AM; Gao, E; Koch, WJ; Schumacher, SM; Tesmer, JJ; Zhu, W | 1 |
| Bernardo, BC; Blaxall, BC | 1 |
| Corti, N; Elke, B; Locher, P; Wagner, CC | 1 |
| Dasgupta, K; Labos, C; Nedjar, H; Rahme, E; Turecki, G | 1 |
| Aizawa, Y; Fujita, S; Hanawa, H; Hayashi, M; Kato, K; Kodama, M; Komura, S; Kondo, D; Minagawa, S; Ohno, Y; Okura, Y; Sato, A | 1 |
| Cines, M; Gottlieb, SS; Greenberg, N; Katzen, S; Kop, WJ; Marshall, J; Minshall, S; Thomas, SA; Vesely, MR | 1 |
2 review(s) available for paroxetine and Heart Failure
| Article | Year |
|---|---|
From Bench to Bedside: New Approaches to Therapeutic Discovery for Heart Failure.
Topics: Angiotensin Receptor Antagonists; Cardiac Myosins; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclohexanes; G-Protein-Coupled Receptor Kinase 2; Heart Failure; Humans; Neprilysin; Oximes; Paroxetine; Piperidines; RNA, Untranslated; Xanthenes | 2016 |
[Frequent drug interactions in old age].
Topics: Adrenergic beta-Antagonists; Age Factors; Antihypertensive Agents; Cytochrome P-450 Enzyme System; Depression; Diuretics; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Heart Failure; Humans; Metoprolol; Paroxetine; Polypharmacy; Risk Factors; Sulfonamides; Torsemide | 2009 |
1 trial(s) available for paroxetine and Heart Failure
| Article | Year |
|---|---|
A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure.
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Delayed-Action Preparations; Depression; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Quality of Life; Treatment Outcome | 2007 |
3 other study(ies) available for paroxetine and Heart Failure
| Article | Year |
|---|---|
Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Fibrosis; G-Protein-Coupled Receptor Kinase 2; Heart Failure; Hemodynamics; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Paroxetine; Receptors, Adrenergic, beta; Translational Research, Biomedical; Ventricular Remodeling | 2015 |
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Canada; Citalopram; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Heart Failure; Hemorrhage; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Neoplasms; Paroxetine; Peptic Ulcer; Platelet Aggregation Inhibitors; Renal Insufficiency; Retrospective Studies; Risk; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Ticlopidine | 2011 |
Life-threatening serotonin syndrome in a patient with chronic heart failure and CYP2D6*1/*5.
Topics: Adult; Chronic Disease; Cytochrome P-450 CYP2D6; Diagnosis, Differential; Electrocardiography; Heart Failure; Humans; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 2004 |